{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:09:18Z","timestamp":1787695758692,"version":"build-2784847793"},"reference-count":45,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Deanship of Scientific Research at Jouf University","award":["DSR-2021-01-0378"],"award-info":[{"award-number":["DSR-2021-01-0378"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Vitamin D supplementation plays a key effect in lowering cytokine storms among COVID-19 patients by influencing the activity of the renin-angiotensin system and the production of the angiotensin-2 converting enzyme. The study was conducted to explore the effect of high-dose intramuscular vitamin D in hospitalized adults infected with moderate-to-severe SARS-CoV-2 in comparison with the standard of care in the COVID-19 protocol. Materials and Methods: Two groups of patients were compared in this prospective randomized controlled trial as the vitamin D was administered orally to group 1 (alfacalcidol 1 mcg\/day) and intramuscularly to group 2 (cholecalciferol 200,000 IU). One hundred and sixteen participants were recruited in total, with fifty-eight patients in each group. Following the Egyptian Ministry of Health\u2019s policy for COVID-19 management, all patients received the same treatment for a minimum of five days. Results: A significant difference was recorded in the length of hospital stay (8.6 versus 6.8 days), need for high oxygen or non-invasive mechanical ventilator (67% versus 33%), need for a mechanical ventilator (25% versus 75%), clinical improvement (45% versus 55%), the occurrence of sepsis (35% versus 65%), and in the monitored laboratory parameters in favor of high-dose vitamin D. Moreover, clinical improvement was significantly associated with the need for low\/high oxygen, an invasive\/non-invasive mechanical ventilator (MV\/NIMV), and diabetes, while mortality was associated with the need for MV, ICU admission, atrial fibrillation, chronic obstructive pulmonary disease, asthma, and the occurrence of secondary infection. Conclusions: Our study showed that high-dose vitamin D was considered a promising treatment in the suppression of cytokine storms among COVID-19 patients and was associated with better clinical improvement and fewer adverse outcomes compared to low-dose vitamin D.<\/jats:p>","DOI":"10.3390\/medicina58101358","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T01:51:49Z","timestamp":1664329909000},"page":"1358","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Evidence for the Efficacy of a High Dose of Vitamin D on the Hyperinflammation State in Moderate-to-Severe COVID-19 Patients: A Randomized Clinical Trial"],"prefix":"10.3390","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4067-5518","authenticated-orcid":false,"given":"Neven","family":"Sarhan","sequence":"first","affiliation":[{"name":"Clinical Pharmacy Department, Faculty of Pharmacy, Misr International University, Cairo 11828, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4434-6217","authenticated-orcid":false,"given":"Ahmed E.","family":"Abou Warda","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department, Faculty of Pharmacy, October 6 University, P.O. Box 12585, Giza 12585, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0781-6454","authenticated-orcid":false,"given":"Rania M.","family":"Sarhan","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, P.O. Box 62514, Beni-Suef 62511, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4916-4359","authenticated-orcid":false,"given":"Marian S.","family":"Boshra","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, P.O. Box 62514, Beni-Suef 62511, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4947-0495","authenticated-orcid":false,"given":"Gomaa","family":"Mostafa-Hedeab","sequence":"additional","affiliation":[{"name":"Pharmacology Department, Medical College, Jouf University, Sakaka 72388, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2034-7709","authenticated-orcid":false,"given":"Bashayer F.","family":"ALruwaili","sequence":"additional","affiliation":[{"name":"Community and Family Medicine Department, Division of Family Medicine, Medical College, Jouf University, Sakaka 72388, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3584-1953","authenticated-orcid":false,"given":"Haytham Soliman Ghareeb","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Cardiology Department, Faculty of Medicine, El-Fayoum University, P.O. Box 63514, El Fayoum 63511, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8569-689X","authenticated-orcid":false,"given":"Mona F.","family":"Schaalan","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department, Faculty of Pharmacy, Misr International University, Cairo 11828, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3626-3040","authenticated-orcid":false,"given":"Shaimaa","family":"Fathy","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department, Faculty of Pharmacy, Misr International University, Cairo 11828, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"106054","DOI":"10.1016\/j.ijantimicag.2020.106054","article-title":"Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): A global pandemic and treatment strategies","volume":"56","author":"Sharma","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Schaalan, M., Warda, A.E.A., Osman, S.M., Fathy, S., Sarhan, R.M., Boshra, M.S., Sarhan, N., Gaber, S., and Ali, A.M.A. (2022). The Impact of Sociodemographic, Nutritional, and Health Factors on the Incidence and Complications of COVID-19 in Egypt: A Cross-Sectional Study. Viruses, 14.","DOI":"10.3390\/v14030448"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/postgradmedj-2020-138712","article-title":"Vitamin D status and outcomes for hospitalized older patients with COVID-19","volume":"97","author":"Baktash","year":"2021","journal-title":"Postgrad. Med. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.kjms.2018.03.004","article-title":"Vitamin D: And its role in breast cancer","volume":"34","year":"2018","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1080\/10408398.2020.1841090","article-title":"Vitamin D deficiency aggravates COVID-19: Systematic review and meta-analysis","volume":"62","author":"Pereira","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_6","first-page":"7","article-title":"Vitamin D in adults: Update on testing and supplementation","volume":"16","author":"Annweiler","year":"2018","journal-title":"Geriatr. Psychol. Neuropsychiatr. Vieil."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.mayocp.2013.05.011","article-title":"Vitamin D for health: A global perspective","volume":"88","author":"Holick","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000486536","article-title":"Vitamin D: Classic and novel actions","volume":"72","author":"Gil","year":"2018","journal-title":"Ann. Nutr. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/jmv.27294","article-title":"Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID-19","volume":"94","author":"Bayraktar","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_10","first-page":"68","article-title":"Magnesium and vitamin D deficiency as a potential cause of immune dysfunction, cytokine storm, and disseminated intravascular coagulation in COVID-19 patients","volume":"118","author":"DiNicolantonio","year":"2021","journal-title":"Mo. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Grant, W.B., Lahore, H., McDonnell, S.L., Baggerly, C.A., French, C.B., Aliano, J.L., and Bhattoa, H.P. (2020). Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients, 12.","DOI":"10.20944\/preprints202003.0235.v2"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1210\/me.2013-1146","article-title":"VDR attenuates acute lung injury by blocking Ang-2-Tie-2 pathway and renin-angiotensin system","volume":"27","author":"Kong","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"29821","DOI":"10.1074\/jbc.M705495200","article-title":"1,25- Dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter","volume":"282","author":"Yuan","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1099\/vir.0.043919-0","article-title":"Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63","volume":"93 Pt 9","author":"Dijkman","year":"2012","journal-title":"J. Gen. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ji, X., Zhang, C., Zhai, Y., Zhang, Z., Zhang, C., Xue, Y., Tan, G., and Niu, G. (2020). TWIRLS, an automated topic-wise inference method based on massive literature, suggests a possible mechanism via ACE2 for the pathological changes in the human host after coronavirus infection. bioRxiv.","DOI":"10.1101\/2020.02.27.967588"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1128\/JVI.02560-09","article-title":"Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway","volume":"84","author":"Chen","year":"2010","journal-title":"J. Virol."},{"key":"ref_18","first-page":"1284","article-title":"Effect of vitamin D on ACE2 and vitamin D receptor expression in rats with LPS-induced acute lung injury","volume":"25","author":"Yang","year":"2016","journal-title":"Chin. J. Emerg. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.eprac.2021.03.006","article-title":"Vitamin D and its potential benefit for the COVID-19 pandemic","volume":"27","author":"Charoenngam","year":"2021","journal-title":"Endocr. Pract."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e214117","DOI":"10.1001\/jamanetworkopen.2021.4117","article-title":"Association of vitamin D levels, race\/ethnicity, and clinical characteristics with COVID-19 test results","volume":"4","author":"Meltzer","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"World Medical Association (2013). Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA, 310, 2191\u20132194.","DOI":"10.1001\/jama.2013.281053"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.11613\/BM.2021.010502","article-title":"Sample size, power and effect size revisited: Simplified and practical approaches in pre-clinical, clinical and laboratory studies","volume":"31","author":"Serdar","year":"2021","journal-title":"Biochem. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jclinepi.2015.04.014","article-title":"A simple formula for the calculation of sample size in pilot studies","volume":"68","author":"Viechtbauer","year":"2015","journal-title":"J. Clin. Epidemiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e14532","DOI":"10.1111\/ijcp.14532","article-title":"Differential clinical diagnosis and prevalence rate of allergic rhinitis, asthma and chronic obstructive pulmonary disease among COVID-19 patients","volume":"75","author":"Sarhan","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.2147\/IJGM.S309003","article-title":"Prevalence of Low Level of Vitamin D Among COVID-19 Patients and Associated Risk Factors in India\u2013A Hospital-Based Study","volume":"14","author":"Singh","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"ref_26","unstructured":"Del Valle, H.B., Yaktine, A.L., Taylor, C.L., and Ross, A.C. (2011). Dietary Reference Intakes for Calcium and Vitamin D., National Academies Press."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nfs.2020.06.001","article-title":"Vitamin D deficiency and co-morbidities in COVID-19 patients\u2013A fatal relationship?","volume":"20","author":"Biesalski","year":"2020","journal-title":"Nfs J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"111017","DOI":"10.1016\/j.nut.2020.111017","article-title":"Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19)","volume":"79","author":"Tan","year":"2020","journal-title":"Nutrition"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"105751","DOI":"10.1016\/j.jsbmb.2020.105751","article-title":"Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study","volume":"203","author":"Miranda","year":"2020","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ling, S.F., Broad, E., Murphy, R., Pappachan, J.M., Pardesi-Newton, S., Kong, M.F., and Jude, E.B. (2020). High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: A cross-sectional multi-centre observational study. Nutrients, 12.","DOI":"10.2139\/ssrn.3690902"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Barrea, L., Gennari, L., Merlotti, D., Mingiano, C., Frosali, A., Giovanelli, L., Torlasco, C., Pengo, M.F., Heilbron, F., and Soranna, D. (2022). Vitamin D: A Role Also in Long COVID-19?. Nutrients, 14.","DOI":"10.3390\/nu14081625"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Campi, I., Gennari, L., Merlotti, D., Mingiano, C., Frosali, A., Giovanelli, L., Torlasco, C., Pengo, M.F., Heilbron, F., and Soranna, D. (2021). Vitamin D and COVID-19 severity and related mortality: A prospective study in Italy. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-06281-7"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"20191","DOI":"10.1038\/s41598-020-77093-z","article-title":"Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers","volume":"10","author":"Jain","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Kaufman, H.W., Niles, J.K., Kroll, M.H., Bi, C., and Holick, M.F. (2020). SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0239252"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e14675","DOI":"10.1111\/ijcp.14675","article-title":"The role of vitamin D in the age of COVID-19: A systematic review and meta-analysis","volume":"75","author":"Ghasemian","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1210\/clinem\/dgab892","article-title":"Prognostic and therapeutic role of vitamin D in COVID-19: Systematic review and meta-analysis","volume":"107","author":"Dissanayake","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12937-021-00744-y","article-title":"Low vitamin D levels do not aggravate COVID-19 risk or death, and vitamin D supplementation does not improve outcomes in hospitalized patients with COVID-19: A meta-analysis and GRADE assessment of cohort studies and RCTs","volume":"20","author":"Chen","year":"2021","journal-title":"Nutr. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"105958","DOI":"10.1016\/j.jsbmb.2021.105958","article-title":"Vitamin D supplementation prior to or during COVID-19 associated with better 3-month survival in geriatric patients: Extension phase of the GERIA-COVID study","volume":"213","author":"Annweiler","year":"2021","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jama.2020.26848","article-title":"Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: A randomized clinical trial","volume":"325","author":"Murai","year":"2021","journal-title":"JAMA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/postgradmedj-2020-139065","article-title":"Short term, high-dose vitamin D supplementation for COVID-19 disease: A randomised, placebo-controlled, study (SHADE study)","volume":"98","author":"Rastogi","year":"2022","journal-title":"Postgrad. Med. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/cid\/cis751","article-title":"Addition of vitamin D status to prognostic scores improves the prediction of outcome in community-acquired pneumonia","volume":"55","author":"Remmelts","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_42","first-page":"250","article-title":"Low Vitamin D status at admission as a risk factor for poor survival in hospitalized patients with COVID-19: An Italian retrospective study","volume":"41","author":"Infante","year":"2022","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"10641","DOI":"10.1038\/s41598-021-90189-4","article-title":"Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease","volume":"11","author":"Lakkireddy","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1186\/s13063-020-04928-5","article-title":"COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): Study protocol for a randomized controlled trial","volume":"21","author":"Annweiler","year":"2020","journal-title":"Trials"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13063-021-05073-3","article-title":"High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL)","volume":"22","author":"Mariani","year":"2021","journal-title":"Trials"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/10\/1358\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:40:40Z","timestamp":1760143240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/10\/1358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["medicina58101358"],"URL":"https:\/\/doi.org\/10.3390\/medicina58101358","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]}}}